FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced results from a new study presented at the ...
Please provide your email address to receive an email when new articles are posted on . Helga P. Sandoval, MD, MSc, discussed visual outcomes of the Eyhance monofocal plus IOL from Johnson & Johnson ...
Please provide your email address to receive an email when new articles are posted on . NEW YORK — In this Healio Video Perspective from OSN New York, Karolinne M. Rocha, MD, PhD, discusses tolerance ...
Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivity
Alcon innovations featured in approximately 180 abstracts across cataract, glaucoma, refractive, visualization and ocular health1 New data demonstrates comparable range of vision and intermediate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results